Clinician's Roundtable

Host: Mark Nolan Hill, MD Guest: James Berenson, MD Extended survival outcomes are becoming increasingly common after a diagnosis of multiple myeloma. What are some of the therapies responsible for these advances, and how far are we extending survival? Further, we’re learning that certain combination therapies are more effective for certain patients. How can we determine which patients are viable candidates for a specific treatment regimen? Dr. James Berenson, founding president and chief executive officer of the Institute for Myeloma and Bone Cancer Research in West Hollywood, Calif., probes these issues and more with host Dr. Mark Nolan Hill.

Host: Matthew J. Sorrentino, MD, FACC, FASH Guest: Lu Wang, MD, PhD Dr. Lu Wang and her colleagues at Harvard Medical School have evaluated the eating habits of a large number of women in the Women’s Health Study and have shown an association between meat, grain and dairy intake and the development of hypertension. Dr. Wang will discuss some of the findings from these studies and give recommendations for a well balanced diet to reduce the risk of developing hypertension.

Host: Matthew J. Sorrentino, MD, FACC, FASH Guest: Lu Wang, MD, PhD Dr. Lu Wang and her colleagues at Harvard Medical School recently published an analysis from the Women’s Health Study showing that intake of low fat dairy products is associated with the lowest incidence of developing hypertension. Dr. Wang will describe her study and discuss the daily dose of dairy products to prevent hypertension.

Host: Susan Dolan, RN, JD Guest: Frederic Luskin, PhD Dr. Luskin holds a PhD in Counseling & Health Psychology from Stanford University, is a Senior Fellow at the Stanford Center on Conflict and Negotiation and is the author of Forgive for Good and Forgive for Love. Hear Dr. Luskin as he discusses how everyone can learn to forgive.

Host: Susan Dolan, RN, JD Guest: Frederic Luskin, PhD Dr. Frederic Luskin is the author of Forgive for Good and Forgive for Love. Hear Dr. Luskin discuss the latest research findings on forgiveness.

Host: Susan Dolan, RN, JD Guest: Doug Wojcieszak, MS Mr. Doug Wojcieszak is the founder and spokesperson for the Sorry Works! Coalition. During this segment, you'll hear Mr. Wojcieszak discuss so-called 'health courts' as a possible solution to the medical malpractice crisis.

Host: Gary Kohn, MD Guest: Don Catlin, MD Looking beyond steroids in professional sports; what are the major drugs, how do they work, and who is using them? Looking at the red blood cell-boosting EPO, HGH, and the future of testing for performance enhancing drugs in sports is your host, Dr. Gary Kohn. Joining him is one of the world's premier authorities on drug testing, Dr. Don Catlin, chief executive of Anti-Doping Research, Inc., in Los Angeles, and the former head of UCLA Olympic Analytical Labs. Dr. Catlin discusses performance enhancing drug use prior to the professional ranks, and a conceptual volunteer program that rewards the non-drug users.

Host: Gary Kohn, MD Guest: Don Catlin, MD As athletes make gains in size, speed, and agility, so do the tests that ensure those athletes are doing so without the assistance of illegal, performance-enhancing substances. Host Dr. Gary Kohn speaks with Dr. Don Catlin, founder and chief executive officer of Anti-Doping Research, Inc., in Los Angeles, and former head of the UCLA Olympic Analytical Labs, who specifically highlights pharmaceutical testosterone, its production signature, and the carbon isotope ratio test that exposes its illegal use.

Host: Gary Kohn, MD Guest: John Bissler, MD Dr. John Bissler, professor of pediatrics at the Cincinnati Children's Hospital Medical Center, in the division of nephrology and hypertension, discusses tuberous sclerosis, its prevalence, and the potential for non-surgical treatment with host Dr. Gary Kohn.

Host: Mark Nolan Hill, MD Guest: Mininder Kocher, MD, MPH In pediatric sports medicine, it is now recognized that ACL injuries are increasingly common in kids. But their still-growing bodies present added risk when considering treatment options, not the least of which is the grueling recovery process following surgery to repair the injury. Dr. Mininder Kocher, associate professor of orthopaedic surgery at Harvard Medical School, and associate director of sports medicine at the Children's Hospital in Boston, assesses the relative risks of operative and non-operative treatment for ACL injuries in young athletes. How can we counsel our young patients who will not have surgery, but also refuse to adjust their activity level? Dr. Mark Nolan Hill hosts.